BRAINSTORM (THE OXFORD BRAIN TUMOUR RESEARCH FOUNDATION) CIO
The Charity aims to find a cure for Brain Tumours.
Financial health, per its FY2025 accounts
The accounts state that unrestricted reserves stood at £198,326, which is below the trustees' stated policy target of approximately £600 (representing 12 weeks of core running costs). The charity reported total income of £51,153 and total expenditure of £6,228, resulting in a net surplus that increased its cash position.
What the accounts disclose
“We have raised funds from patients and their families as our main source of funding.” — page 4
“The Charity aims for a reserve fund of 12 weeks core running costs to be held in unrestricted funds which amounts to approximately £600.”
Trustees
- PETER ANTHONY ERSKINE
- RICHARD STACEY MB BS FRCS
- ROWEN PESTANA
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/05/2025 | £51k | £6k |
| 31/05/2024 | £49k | £101k |
| 31/05/2023 | £113k | £7k |
| 31/05/2022 | £51k | £5k |
| 31/05/2021 | £26k | £54k |
Common questions
Is BRAINSTORM (THE OXFORD BRAIN TUMOUR RESEARCH FOUNDATION) CIO financially healthy?
Per its FY2025 accounts: The accounts state that unrestricted reserves stood at £198,326, which is below the trustees' stated policy target of approximately £600 (representing 12 weeks of core running costs). The charity reported total income of £51,153 and total expenditure of £6,228, resulting in a net surplus that increased its cash position. Its FY2025 accounts were independently examined.